Pfizer
Patents, Design & Utilities
Last updated:
List of all Pfizer patents 451 in total
| Status | Patent |
|---|---|
Grant | Utility: Glycoconjugation processes and compositions Filling date: 13 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION Filling date: 13 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Combinations For Treatment Of NASH/NAFLD And Related Diseases Filling date: 13 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 27 Feb 2020 |
Grant | Utility: Substituted dihydroisoquinolinone compounds Filling date: 13 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Muteins of clotting factor VIII Filling date: 13 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer Filling date: 13 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: TYROSINE PROTOTROPHY Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: Therapeutic Polymeric Nanoparticles Comprising Lipids and Methods of Making and Using Same Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER Filling date: 13 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: RORC2 INHIBITORS AND METHODS OF USE THEREOF Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR EVENTS AND RELTED DISEASES USING SGLT-2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: AMINOPYRIMIDINYL COMPOUNDS Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Grant | Utility: Neisseria meningitidis composition and methods thereof Filling date: 13 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Tissue factor pathway inhibitor antibodies and uses thereof Filling date: 13 Sep 2025 Issue date: 4 Feb 2020 |
Application | Utility: COMPOSITION COMPRISING AVELUMAB Filling date: 13 Sep 2025 Issue date: 30 Jan 2020 |
Grant | Utility: Neisseria meningitidis compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Anti-IL-33 antibodies, compositions, methods and uses thereof Filling date: 13 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: 3-indol substituted derivatives, pharmaceutical compositions and methods for use Filling date: 13 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Method of cell culture Filling date: 13 Sep 2025 Issue date: 28 Jan 2020 |
Application | Utility: ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING Filling date: 13 Sep 2025 Issue date: 23 Jan 2020 |
Grant | Utility: Cyclopentane-based modulators of STING (stimulator of interferon genes) Filling date: 13 Sep 2025 Issue date: 21 Jan 2020 |
Application | Utility: AQUEOUS ANTI-PD-L1 ANTIBODY FORMULATION Filling date: 13 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: ANTIBODIES SPECIFIC FOR GUCY2C AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH Filling date: 13 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[- 5,4,3-CD]INDOL-6-ONE Filling date: 13 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: MULTI-SITE SPECIFIC INTEGRATION CELLS FOR DIFFICULT TO EXPRESS PROTEINS Filling date: 13 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof Filling date: 13 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: 1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYAN- OPHENYL)UREA MALEATE Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: ANTIBODIES SPECIFIC FOR CD3 AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: LARGE SCALE PRODUCTION PROCESS FOR CAPPED AND UN-CAPPED ANTIBODY CYSTEINES AND THEIR USE IN THERAPEUTIC PROTEIN CONJUGATION Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Grant | Utility: Intermediates and methods for synthesizing calicheamicin derivatives Filling date: 13 Sep 2025 Issue date: 17 Dec 2019 |
Grant | Utility: SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease Filling date: 13 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Design: Therapeutic wrap Filling date: 13 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Design: Therapeutic wrap Filling date: 13 Sep 2025 Issue date: 10 Dec 2019 |
Application | Utility: HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: CRYSTALLINE FORM OF LORLATINIB FREE BASE Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: PURIFICATION OF ANTIBODY DRUG CONJUGATES USING A SODIUM PHOSPHATE GRADIENT Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Grant | Design: Therapeutic wrap Filling date: 13 Sep 2025 Issue date: 3 Dec 2019 |
Grant | Design: Therapeutic wrap Filling date: 13 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: CALICHEAMICIN DERATIVES AND ANTIBODY DRUG CONJUGATES THEREOF Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: Immunogenic Compositions for Use in Pneumococcal Vaccines Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Showing 350 to 400 of 451 patents.